Opt-In, Investment and Additional Consideration Agreement Sample Contracts

Confidential

Opt-In, Investment and Additional Consideration Agreement • October 1st, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations

• Contract Type
  Opt-In, Investment and Additional Consideration Agreement
• Filed
  October 1st, 2021
• Company
  Pyxis Oncology, Inc.
• Industry
  Pharmaceutical preparations

THIS AMENDMENT TO OPT-IN, INVESTMENT AND ADDITIONAL CONSIDERATION AGREEMENT (the “Amendment”) is made as of August 2, 2021, to be effective as of January 1, 2021 (“Effective Date”) as part of the License between the Parties (each as defined below).

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Opt-In, Investment and Additional Consideration Agreement • September 17th, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations • Massachusetts

• Contract Type
  Opt-In, Investment and Additional Consideration Agreement
• Filed
  September 17th, 2021
• Company
  Pyxis Oncology, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Massachusetts

THIS OPT-IN, INVESTMENT AND ADDITIONAL CONSIDERATION AGREEMENT (the “Opt-In Agreement”) is made on December 1, 2020 (“Effective Date”) as part of the License between the Parties (each as defined below).